What to watch with ADH1B and menopause?

ADH1B encodes alcohol dehydrogenase, which converts ethanol to acetaldehyde. During menopause, hormonal shifts (especially estrogen decline) can alter alcohol sensitivity and metabolism. Carriers of fast-metabolizing ADH1B variants (e.g., rs1229984, common in East Asians) experience higher acetaldehyde levels, potentially worsening menopausal symptoms like hot flashes, nausea, and increasing cancer risk (particularly breast cancer). Postmenopausal estrogen reduction may further decrease hepatic alcohol dehydrogenase activity, possibly amplifying acetaldehyde accumulation in fast metabolizers. Evidence is mostly mechanistic and observational; no RCTs specifically address ADH1B–menopause interactions. Clinically, moderate alcohol tolerance often changes during menopause. A genetic test can offer insight but does not replace medical advice. Caveat: ADH1B is one piece; lifestyle, liver function, and other genes also matter.